Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Letrozole
Sponsor: Novartis Pharmaceuticals